Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region

Most disease-modifying drugs (DMDs) are contraindicated in pregnancy. Management of MS is especially challenging for pregnant patients, as withdrawal of DMDs leave the patient at risk of increased disease activity. We, a group of experts in MS care from countries in the Arab Gulf, present our consen...

Descripción completa

Detalles Bibliográficos
Autores principales: Alroughani, Raed, Inshasi, Jihad, Al-Asmi, Abdullah, Alkhabouri, Jaber, Alsaadi, Taoufik, Alsalti, Abdullah, Boshra, Amir, Canibano, Beatriz, Ahmed, Samar Farouk, Shatila, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606397/
https://www.ncbi.nlm.nih.gov/pubmed/32564333
http://dx.doi.org/10.1007/s40120-020-00201-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606397/
https://www.ncbi.nlm.nih.gov/pubmed/32564333
http://dx.doi.org/10.1007/s40120-020-00201-8

Ejemplares similares